pentaerythritol tetranitrate has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giani, G; Haastert, B; Icks, A; Rathmann, W; Schröder-Bernhardi, D | 1 |
1 other study(ies) available for pentaerythritol tetranitrate and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Cost comparison analysis: pentaerythrithyl tetranitrate (PETN) and isosorbide dinitrate (ISDN) prescribed to diabetic patients in primary care practices in Germany.
Topics: Aged; Aged, 80 and over; Cost-Benefit Analysis; Databases, Factual; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Germany, East; Germany, West; Humans; Isosorbide Dinitrate; Male; Multivariate Analysis; Myocardial Ischemia; Pentaerythritol Tetranitrate; Practice Patterns, Physicians'; Primary Health Care; Regression Analysis; Vasodilator Agents | 2007 |